Merck
HomeWebinarsA Holistic Approach to Upstream Viral Safety

A Holistic Approach to Upstream Viral Safety



WEBINAR

All biologics production processes focus on preventing adventitious microorganisms from entering upstream processes. Regulatory guidance for upstream processes focuses on comprehensive testing and characterization of raw materials. While there is no specific mandate for implementing viral clearance technologies, manufacturers are increasingly implementing practices that mitigate the risk of contamination and the consequent disruption to manufacturing operations. This webinar will discuss the potential sources of viral contaminants, the strengths, and limitations of different detection and removal technologies as well as explain how they can be integrated into a comprehensive, holistic, upstream viral safety strategy.

In this webinar, you will learn about:

  • How integrating multiple approaches can reduce contamination risks
  • Retention performance with different filters for cell culture media processing

Speaker

Craig Jackson

Craig Jackson

Merck

Senior Product Manager

Craig has more than 20 years of experience in the biotech industry and has always worked directly with biopharmaceutical manufacturers. His breadth of experience includes lab-scale process development, commercial process troubleshooting and optimization, new product introductions to the marketplace, and commissioning of new manufacturing plants. His current role encompasses virus risk reduction in all areas of the biomanufacturing process, with a focus on upstream virus risk mitigation. Craig has a B.S. in chemical engineering from the University of Massachusetts at Amherst.

Webinar Information

Pharma and biopharma manufacturing

  • Viral Vector Upstream Processing
  • Duration:36min

  • Language:English

  • Presented:Thu, March 5, 2020

    Watch Now